BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 32474947)

  • 21. A clinicopathological description of COVID-19-induced chilblains (COVID-toes) correlated with a published literature review.
    Kolivras A; Thompson C; Pastushenko I; Mathieu M; Bruderer P; de Vicq M; Feoli F; Harag S; Meiers I; Olemans C; Sass U; Dehavay F; Fakih A; Lam-Hoai XL; Marneffe A; Van De Borne L; Vandersleyen V; Richert B
    J Cutan Pathol; 2022 Jan; 49(1):17-28. PubMed ID: 34272741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chilblain-like lesions with prominent bullae in a patient with COVID-19.
    Rubin A; Alamgir M; Rubin J; Rao BK
    BMJ Case Rep; 2020 Nov; 13(11):. PubMed ID: 33139373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clustered cases of acral perniosis: Clinical features, histopathology, and relationship to COVID-19.
    Cordoro KM; Reynolds SD; Wattier R; McCalmont TH
    Pediatr Dermatol; 2020 May; 37(3):419-423. PubMed ID: 32396999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chilblain-like lesions coinciding with the SARS-CoV-2 pandemic.
    Starkey SY; Mar K; Kashetsky N; Lam JM; Dutz J; Mukovozov I
    Clin Dermatol; 2023; 41(1):223-229. PubMed ID: 36228990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outbreak of chilblain-like acral lesions in children in the metropolitan area of Milan, Italy, during the COVID-19 pandemic.
    Colonna C; Genovese G; Monzani NA; Picca M; Boggio F; Gianotti R; Marzano AV
    J Am Acad Dermatol; 2020 Sep; 83(3):965-969. PubMed ID: 32534082
    [No Abstract]   [Full Text] [Related]  

  • 26. Chilblain-like lesions during the COVID-19 pandemic: should we really worry?
    Piccolo V; Neri I; Manunza F; Mazzatenta C; Bassi A
    Int J Dermatol; 2020 Aug; 59(8):1026-1027. PubMed ID: 32496583
    [No Abstract]   [Full Text] [Related]  

  • 27. Lack of association between pandemic chilblains and SARS-CoV-2 infection.
    Gehlhausen JR; Little AJ; Ko CJ; Emmenegger M; Lucas C; Wong P; Klein J; Lu P; Mao T; Jaycox J; Wang E; ; Ugwu N; Muenker C; Mekael D; Klein RQ; Patrignelli R; Antaya R; McNiff J; Damsky W; Kamath K; Shon J; Ring AM; Yildirim I; Omer S; Ko AI; Aguzzi A; Iwasaki A
    Proc Natl Acad Sci U S A; 2022 Mar; 119(9):. PubMed ID: 35217624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Going viral: A brief history of Chilblain-like skin lesions ("COVID toes") amidst the COVID-19 pandemic.
    Massey PR; Jones KM
    Semin Oncol; 2020 Oct; 47(5):330-334. PubMed ID: 32736881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histopathology of persistent long COVID toe: A case report.
    Nirenberg MS; Requena L; Santonja C; Smith GT; McClain SA
    J Cutan Pathol; 2022 Sep; 49(9):791-794. PubMed ID: 35366017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chilblain-like lesions in children following suspected COVID-19 infection.
    Colonna C; Monzani NA; Rocchi A; Gianotti R; Boggio F; Gelmetti C
    Pediatr Dermatol; 2020 May; 37(3):437-440. PubMed ID: 32374033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SARS-CoV-2 spike protein is present in both endothelial and eccrine cells of a chilblain-like skin lesion.
    Gambichler T; Reuther J; Stücker M; Stranzenbach R; Torres-Reyes C; Schlottmann R; Schmidt WE; Hayajneh R; Sriram A; Becker JC
    J Eur Acad Dermatol Venereol; 2021 Mar; 35(3):e187-e189. PubMed ID: 33002210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discordant anti-SARS-CoV-2 spike protein and RNA staining in cutaneous perniotic lesions suggests endothelial deposition of cleaved spike protein.
    Ko CJ; Harigopal M; Gehlhausen JR; Bosenberg M; McNiff JM; Damsky W
    J Cutan Pathol; 2021 Jan; 48(1):47-52. PubMed ID: 32895985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pediatric COVID toes and fingers.
    Koschitzky M; Oyola RR; Lee-Wong M; Abittan B; Silverberg N
    Clin Dermatol; 2021; 39(1):84-91. PubMed ID: 33972057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Are SARS-CoV-2 IgA antibodies in paediatric patients with chilblain-like lesions indicative of COVID-19 asymptomatic or paucisymptomatic infection?
    Diociaiuti A; Giancristoforo S; Terreri S; Corbeddu M; Concato C; Ciofi Degli Atti M; Zambruno G; Carsetti R; El Hachem M
    J Eur Acad Dermatol Venereol; 2021 Jan; 35(1):e10-e13. PubMed ID: 32920919
    [No Abstract]   [Full Text] [Related]  

  • 35. Evaluation of Chilblains as a Manifestation of the COVID-19 Pandemic.
    Herman A; Peeters C; Verroken A; Tromme I; Tennstedt D; Marot L; Dachelet C; Gruson D; Hermans C; Baeck M
    JAMA Dermatol; 2020 Sep; 156(9):998-1003. PubMed ID: 32584377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of Sars-Cov-2 Infection in Health Workers (HWs) and Diagnostic Test Performance: The Experience of a Teaching Hospital in Central Italy.
    Lahner E; Dilaghi E; Prestigiacomo C; Alessio G; Marcellini L; Simmaco M; Santino I; Orsi GB; Anibaldi P; Marcolongo A; Annibale B; Napoli C
    Int J Environ Res Public Health; 2020 Jun; 17(12):. PubMed ID: 32575505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Do we have serological evidences that chilblain-like lesions are related to SARS-CoV-2? A review of the literature.
    Balestri R; Magnano M; Rizzoli L; Rech G
    Dermatol Ther; 2020 Nov; 33(6):e14229. PubMed ID: 32844512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Skin lesions in children during the first wave of the SARS-CoV-2 pandemic.
    Carazo Gallego B; Martín Pedraz L; Galindo Zavala R; Rivera Cuello M; Mediavilla Gradolph C; Núñez Cuadros E
    Med Clin (Barc); 2021 Jul; 157(1):33-37. PubMed ID: 34016448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Skin manifestations of COVID-19 in children: Part 1.
    Andina D; Belloni-Fortina A; Bodemer C; Bonifazi E; Chiriac A; Colmenero I; Diociaiuti A; El-Hachem M; Fertitta L; van Gysel D; Hernández-Martín A; Hubiche T; Luca C; Martos-Cabrera L; Maruani A; Mazzotta F; Akkaya AD; Casals M; Ferrando J; Grimalt R; Grozdev I; Kinsler V; Morren MA; Munisami M; Nanda A; Novoa MP; Ott H; Pasmans S; Salavastru C; Zawar V; Torrelo A;
    Clin Exp Dermatol; 2021 Apr; 46(3):444-450. PubMed ID: 33180982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. No evidence of SARS-CoV-2 infection by polymerase chain reaction or serology in children with pseudo-chilblain.
    Caselli D; Chironna M; Loconsole D; Nigri L; Mazzotta F; Bonamonte D; Aricò M
    Br J Dermatol; 2020 Oct; 183(4):784-785. PubMed ID: 32613638
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.